Five-fraction SRBT schedule well tolerated with high tumor-control rate in central lung cancersApril 9, 2019Lung Cancer
Acute Encephalopathy Following Hyperbaric Oxygen Therapy in a Patient on MetronidazoleApril 8, 2019Oncology
Preclinical findings highlight value of Lynch syndrome for cancer vaccine developmentApril 8, 2019Oncology
Polatuzumab outperforms pinatuzumab in non-Hodgkin lymphomaApril 5, 2019Lymphoma & Plasma Cell Disorders
ASCO, CCO issue multiple myeloma treatment guidelinesApril 4, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
UNITY-NHL: Interim findings show activity, tolerability of umbralisib for R/R MZLApril 2, 2019Lymphoma & Plasma Cell Disorders
Ibrutinib sustained responses in refractory CLL in long-term follow-upMarch 27, 2019Leukemia, Myelodysplasia, Transplantation
FDA panel calls for changes to breast implant rupture screeningMarch 27, 2019OncologyLymphoma & Plasma Cell Disorders
